Rare should not mean forgotten.
Raising Rare is a registered non-profit advancing awareness and research for FBXO11-related syndrome - and helping families understand how to begin the journey from diagnosis to scientific action.
01
Build Awareness
Make FBXO11 easier for families, clinicians and researchers to find.
02
Advance Research
Support rigorous work toward understanding disease mechanisms and therapeutic possibilities.
03
Connect Families
Share credible starting points, questions and organizations - not false promises
04
Show the path
Explain the long, evidence-based journey from an idea to a possible therapy
WHY WE EXIST
"There is nothing you can do" cannot be the end of the conversation
A rare diagnosis can leave families with more questions than answers. We created Raising Rare after beginning this journey for our daughter, Rylee.
Our goal is not to promise a cure. It is to create informed momentum: connect the right people, fund responsible research, share what we learn and help other families find a credible place to start.
FBXO11 AT A GLANCE
A newly recognized neurodevelopmental condition
FBXO11-related syndrome is associated with changes in the FBXO11 gene. Reported features vary from person to person and can include developmental and language delays, intellectual disability, low muscle tone, autism-related features and seizures. Information is still limited, which is why participation, data and research matter.
The gene
FBXO11 has important cellular functions, and disease-associated variants may disrupt how the protein works
The people
Every person with FBXO11-related syndrome is unique. While individuals may share certain characteristics, their abilities, needs and experiences can vary significantly.
The opportunity
Registries, natural-history information and laboratory models can help researchers ask better questions.
RESEARCH JOURNEY
Hope is strongest when it is transparent.
Understand
Build disease models and study how specific FBXO11 variants affect cells.
Validate
Confirm the biological mechanism and identify measurable research endpoints.
Explore
Evaluate potential therapeutic approaches with qualified research partners
Therapy development is not a straight line. Progress should be described by completed work, evidence, next decisions and remaining uncertainty.
1
2
3
4
Translate
If evidence supports it, progress through preclinical, regulatory and clinical pathways
Fund research, connect expertise, share credible information or bring another family into the community.